Cancer statistics, 2014
- PMID: 24399786
- DOI: 10.3322/caac.21208
Cancer statistics, 2014
Erratum in
- CA Cancer J Clin. 2014 Sep-Oct;64(5):364
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics. A total of 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014. During the most recent 5 years for which there are data (2006-2010), delay-adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.4% per year in women. The combined cancer death rate (deaths per 100,000 population) has been continuously declining for 2 decades, from a peak of 215.1 in 1991 to 171.8 in 2010. This 20% decline translates to the avoidance of approximately 1,340,400 cancer deaths (952,700 among men and 387,700 among women) during this time period. The magnitude of the decline in cancer death rates from 1991 to 2010 varies substantially by age, race, and sex, ranging from no decline among white women aged 80 years and older to a 55% decline among black men aged 40 years to 49 years. Notably, black men experienced the largest drop within every 10-year age group. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population.
Keywords: cancer; epidemiology; health disparities; incidence; survival; trends.
© 2014 American Cancer Society, Inc.
Similar articles
-
Cancer statistics, 2015.CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5. CA Cancer J Clin. 2015. PMID: 25559415
-
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17. CA Cancer J Clin. 2011. PMID: 21685461
-
Cancer statistics, 2013.CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17. CA Cancer J Clin. 2013. PMID: 23335087
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
-
Cancer statistics, 2004.CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
Cited by
-
Risk factors of surgical compliance and impact on survival in patients with kidney cancer: a population-based, propensity score matching study.Langenbecks Arch Surg. 2024 Nov 14;409(1):348. doi: 10.1007/s00423-024-03542-2. Langenbecks Arch Surg. 2024. PMID: 39540950
-
Causality Between Immune Cells, Metabolites and Breast Cancer: Mendelian Randomization and Mediation Analysis.Biochem Genet. 2024 Nov 8. doi: 10.1007/s10528-024-10966-4. Online ahead of print. Biochem Genet. 2024. PMID: 39514081
-
PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor-based First-line Therapy in Metastatic Renal Cell Carcinoma Patients.Eur Urol Open Sci. 2024 Oct 14;70:28-35. doi: 10.1016/j.euros.2024.09.002. eCollection 2024 Dec. Eur Urol Open Sci. 2024. PMID: 39483517 Free PMC article.
-
Pterostilbene suppresses head and neck cancer cell proliferation via induction of apoptosis.Turk J Biol. 2024 Aug 27;48(5):319-337. doi: 10.55730/1300-0152.2708. eCollection 2024. Turk J Biol. 2024. PMID: 39474042 Free PMC article.
-
Comparative Proteomics of ccRCC Cell Lines to Identify Kidney Cancer Progression Factors.Cancer Genomics Proteomics. 2024 Nov-Dec;21(6):645-652. doi: 10.21873/cgp.20480. Cancer Genomics Proteomics. 2024. PMID: 39467626 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
